Mark assumed leadership of Ekam in 2010. He has over 20 years experience in both contract research and pharmaceutical firms. Over a 10 year period, Mark built Primedica Corporation’s Pharmacology and Experimental Surgery program to $18MM in revenue and led the Interventional and Surgical Services Group at Charles River Laboratories to $26MM annual revenue. From 1987-1996, he lead preclinical pharmacology at Centocor.

Peter is a serial entrepreneur and life sciences investor. As President of Primedica Corp, he led the CRO to revenues of $72MM and a sale to Charles River Labs. As CEO of Cohesive Technologies, he led the placement of hundreds of advanced chromatography systems into high throughput labs and a sale to Thermo Fisher Scientific. He is Chairman of Agilux Laboratories and Blue Sky Biotech, and has served as a General Partner at Ampersand Ventures.

Dr Ferris has pioneered the field of awake animal MRI. Craig is a professor of Psychology and Pharmaceutical Sciences at Northeastern University and Director of its Center for Translational Neuroimaging (CTNI). Prior to his appointments at Northeastern, he was Professor of Psychiatry and Physiology and Director of the Center for Comparative Neuroimaging at the University of Massachusetts Medical School.

Praveen is an expert in the areas of functional MRI data analysis, 3D visualization and digital atlas development. Collaborating with Dr. Ferris, he developed many of the analytical tools, visualization techniques and digital atlases that are an important part of the IP portfolio and service offering of Ekam. Praveen obtained his PhD in math from WPI and did his post-doctoral work under Craig Ferris at UMass Medical School.